Loading...
This week, Journal Watch Cardiology, Physician's First Watch, and CardioExchange, an online forum for cardiology news and discussion, have brought you coverage of study findings presented at the American Heart Association's Scientific Sessions in Orlando. A rundown of that coverage:
ISAR-REACT 4 (Kastrati et al.): Abciximab plus unfractionated heparin versus bivalirudin in patients with non-ST-segment-elevation myocardial infarction (NSTEMI) undergoing percutaneous coronary intervention (PCI).
Journal Watch coverage (Free)
CardioExchange blog (Free with registration)
ADOPT (Goldhaber et al.): Extended anticoagulant prophylaxis in initially hospitalized medically ill patients.
Physician's First Watch coverage (Free)
CardioExchange blog (Free with …